  
|
|
 |  |  |  |  |  |  |  |  |
|
Acute Coronary Syndromes
|
|
|
The Food and Drug Administration’s Cardiovascular and Renal Drugs Advisory Committee will be asked at a May 23 meeting whether the advantage seen with Johnson & Johnson/Bayer HealthCare AG’s Xarelto (rivaroxaban) in acute coronary syndromes is undermined by the extent of missing data in the... »
Approval of Generic Clopidogrel a Boon for Patients or Payors?
UPDATED 5/19/12: Just as Sanofi-Aventis loses its exclusivity for its blockbuster drug Plavix (clopidogrel) this month, several generic formulations of the antiplatelet agent have been approved, the Food and Drug Administration announced on May 17. In the FDA statement announcing the approval,... »
Stress Echo in Asymptomatic Revascularized Patients Not Useful
Routine exercise stress echocardiography may not be warranted in asymptomatic patients after coronary revascularization because even though it may identify those at high risk, this does not improve patient outcomes, according to a report published online May 14 in Archives of Internal... »
The Food and Drug Administration’s Cardiovascular and Renal Drugs Advisory Committee will be asked at a May 23 meeting whether the advantage seen with Johnson & Johnson/Bayer HealthCare AG’s Xarelto (rivaroxaban) in... »
Approval of Generic Clopidogrel a Boon for Patients or Payors?
UPDATED 5/19/12: Just as Sanofi-Aventis loses its exclusivity for its blockbuster drug Plavix (clopidogrel) this month, several generic formulations of the antiplatelet agent have been approved, the Food and Drug... »
Stress Echo in Asymptomatic Revascularized Patients Not Useful
Routine exercise stress echocardiography may not be warranted in asymptomatic patients after coronary revascularization because even though it may identify those at high risk, this does not improve patient outcomes,... »
CHICAGO – Cardiac CT angiography in the emergency department safely redirects to home the many patients who would otherwise be admitted for acute chest pain, according to results of the prospective, randomized ACRIN PA 4005... »
Vorapaxar Cuts Cardiovascular Events but Boosts Bleeding
CHICAGO – Vorapaxar, a new type of platelet inhibitor drug, showed unequivocal efficacy for preventing new cardiovascular events in patients with a history of myocardial infarction, stroke, or peripheral artery disease... »
Dr. Hani N. Sabbah Nearly a decade after the first in-man trial to test the efficacy and safety of using stem cells to treat acute myocardial infarction, and after numerous other small phase II clinical trials, we still... »
Preventing Atherothrombotic Events? It's Complicated
When researchers reported earlier this week at the American College of Cardiology’s annual meeting results from the TRA 2P-TIMI 50 trial, which tested a novel anticoagulant drug, vorapaxar, for preventing cardiovascular... »
Empowering Patients: Do They REALLY Know What DNR Means?
Just the mention of code status to patients and their families often turns a (sometimes feined) upbeat demeanor into a solemn one. While the mere mention of even a remote possibility of dying understandably makes patients... »
| May 21 - 25 Sarasota, FL | American Medical Seminars: Cardiology Update in Primary Care |
| Jun 9 - 12 Vancouver, | World Society for Cardio-Thoracic Surgeons (WSCTS): 22nd World Congress |
| Jun 12 London, | Bypass, Balloon Pumps and Circulatory Support |
| Jun 14 - 15 Montreal, | Montreal Heart Institute: Interventional Cardiology Symposium |
| Jun 14 - 24 Departs Copenhagen, | Primary Care Update: Cardiac Health, Metabolic Syndrome, Obesity and Related Disorders |
| Jun 28 - 30 Frankfurt, | Congenital and Structural Interventions (CSI 2012) |
| Jun 30 - Jul 3 National Harbor, MD | American Society of Echocardiography (ASE): Annual Scientific Sessions |
| Jul 27 - 30 Toronto, | International Academy of Cardiology: World Congress on Heart Disease |
| Aug 10 - 13 Jackson Hole, WY | Saint Joseph's Hospital: Annual Tutorials in the Tetons |
| Aug 16 - 19 South Bank, | Cardiac Society of Australia & New Zealand (CSANZ): Annual Scientific Meeting |